There is no real offer for VVUS as Aspen does not have the shares to complete the deal instead lilely pumped VVUS yesterday for a quick buck and got out. VVUS still closed below $5. Most VVUS longs like Van bought above $19 btw.
In the form of 2 generic drugs. Smart investors know there is nothing new here with reformulated Contrave, and OREX will likely suffer the same fate as VVUS did with trying to market their also outdated generic combo Qsymia. June 10th looks to be time to sell or even a great opportunity to short OREX with a REMS FDA approval announcement pending.
The time to have bought OREX was back in the $1's January 2012. Those investors mostly non retail institutions are looking to get out within next 2 weeks when wall street sells the FDA news.
Problem with your theory is "Contrave" has been on the market already for many years in the form of generic drugs so nobody invested here with Belviq is deeply worried. Besides "Belphen" will be the combo of choice and is already starting to be prescribed here in US wit generic phen added to Belviq. Belviq responders have shown to lose on average 11% weight on a single agent drug. ARNA did extensive studies including CVOT on 8,000 people during trials.
Another problem with your theory is you are posting to longs holding major profits while over 40 million shares short are still riding losses from early 2012 including 19 million shares shorted under $3. Do you actually think someone will sell Tuesday because of your post? You are only awakening buyers... good luck covering.
No more milestones Van? I can see why you are continuously on the wrong side of this trade.
Fred doesn't yet realize many longs already bought under $2 after the original deal with Eisai and again under $5 last November.
Funny that the only ones here complaining about ARNA being corrupt are the underwater shorts. Right Fred?
May want to add lgeneric drugsl to that lack of understanding. Qsymia and Contrave have been sold as generics for many years. Most retail investors here know this very well.
SEC has been working overtime reading all these impersonating posts by hedge fund and Yahoo employees. Longs here know wall street trapped themselves without any way to cover millions of shares from 2 years ago right before adcomm. Even if we get a sudden bear raid many longs will be adding not selling.
Did you know the longs were all here at $1.21 and told all hedge funds to cover as early as $1.28 during May 2011? Who's fault is it that hedge funds doubled down short ARNA below $2.44 prior to 2012 adcomm? Certainly not ARNA longs.
We already know from FDA trial data Belviq responders lose on average 11% weight loss. Not good enough for your hedge fund boss sitting on ARNA short losses? That's too bad for your boss.
Nobody here is concerned other than bashers. "Contrave" has been on the market already for many years as generic drugs. I wouldn't but you can go to your doctor today and get a generic Contrave prescription. No need to wait for June FDA response.
OK very well. Impress us by covering your November short trade. Then I'll believe you.
Don't worry from what I've been told your entire Yahoo member posting file was copied and forwarded.
hedge.risk did you know you were named in an SEC complaint today?
Nobody is forcing you to stay here Fred you can cover at any time you like. Over 350 bashing posts for your 1st month yet? I know you are very close.